Dalian, China

Renwu Jiang

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Renwu Jiang. Retrieved from https://idiyas.com/inventor/renwu-jiang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Renwu Jiang: Innovator in Antiviral Compounds

Introduction

Renwu Jiang is a notable inventor based in Dalian, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. His innovative work has led to the creation of a unique compound that holds promise for treating viral diseases.

Latest Patents

Renwu Jiang holds a patent for a phillygenin glucuronic acid derivative, which is described as a general formula (I). This compound is characterized by various configurations of R groups, including R=H, R=CH, and others. The invention not only details the preparation method of this compound but also its application in pharmaceutical compositions aimed at combating antiviral diseases. He has 1 patent to his name.

Career Highlights

Throughout his career, Renwu Jiang has demonstrated a commitment to advancing medical science through his innovative research. His work has been recognized for its potential impact on the treatment of viral infections, showcasing his expertise in pharmaceutical chemistry.

Collaborations

Renwu Jiang has collaborated with notable colleagues, including Yu Zhang and Zhengxian Liu. Their combined efforts have contributed to the advancement of research in the field of antiviral compounds.

Conclusion

Renwu Jiang's contributions to the field of pharmaceuticals, particularly through his patented work on phillygenin glucuronic acid derivatives, highlight his role as an innovator in antiviral research. His ongoing efforts continue to pave the way for new therapeutic options in the fight against viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…